{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T16:11:40Z","timestamp":1784563900855,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.ijrobp.2016.10.047","type":"journal-article","created":{"date-parts":[[2016,11,8]],"date-time":"2016-11-08T05:45:28Z","timestamp":1478583928000},"page":"270-277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Patterns of Relapse in High-Risk Neuroblastoma Patients Treated With and Without Total Body Irradiation"],"prefix":"10.1016","volume":"97","author":[{"given":"Richard","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexei","family":"Polishchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"DuBois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie W.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochelle","family":"Bagatell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Shusterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Hill-Kayser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Al-Sayegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Diller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne A.","family":"Haas-Kogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine K.","family":"Matthay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy B.","family":"London","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen J.","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2016.10.047_bib1","series-title":"Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995, National Cancer Institute, SEER Program [NIH publication 99-4649]","year":"1999"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib2","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1200\/JCO.2003.07.142","article-title":"Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy","volume":"21","author":"Kushner","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib3","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/sj.bjc.6605621","article-title":"Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: A report for the International Neuroblastoma Risk Group (INRG) Task Force","volume":"102","author":"Matthay","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1200\/JCO.2008.16.6785","article-title":"The International Neuroblastoma Risk Group (INRG) classification system: An INRG Task Force report","volume":"27","author":"Cohn","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib5","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1200\/JCO.2008.16.6876","article-title":"The International Neuroblastoma Risk Group (INRG) staging system: An INRG Task Force report","volume":"27","author":"Monclair","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib6","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0022-3468(89)80277-5","article-title":"A surgical perspective on the current staging in neuroblastoma\u2014The International Neuroblastoma Staging System proposal","volume":"24","author":"Smith","year":"1989","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib7","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/bmt.2012.276","article-title":"A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children's Oncology Group study ANBL00P1","volume":"48","author":"Seif","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib8","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S1470-2045(13)70309-7","article-title":"Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): A randomised phase 3 trial","volume":"14","author":"Kreissman","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib9","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa0911123","article-title":"Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma","volume":"363","author":"Yu","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib10","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.ijrobp.2008.10.069","article-title":"Excellent local control from radiation therapy for high-risk neuroblastoma","volume":"74","author":"Gatcombe","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib11","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/00043426-200312000-00005","article-title":"Primary tumor control in patients with stage 3\/4 unfavorable neuroblastoma treated with tandem double autologous stem cell transplants","volume":"25","author":"Marcus","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib12","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jpedsurg.2009.11.003","article-title":"Radiation therapy as part of local control of metastatic neuroblastoma: The St Jude Children's Research Hospital experience","volume":"45","author":"Robbins","year":"2010","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib13","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/pbc.24350","article-title":"Intensity modulated radiation therapy provides excellent local control in high-risk abdominal neuroblastoma","volume":"60","author":"Pai Panandiker","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib14","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1200\/JCO.2001.19.11.2821","article-title":"Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery","volume":"19","author":"Kushner","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib15","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/cncr.20091","article-title":"Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma","volume":"100","author":"Bradfield","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0360-3016(02)04506-6","article-title":"Impact of radiotherapy for high-risk neuroblastoma: A Children's Cancer Group study","volume":"56","author":"Haas-Kogan","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib17","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1200\/JCO.2006.05.6986","article-title":"High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: Long-term survival update","volume":"24","author":"George","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib18","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1056\/NEJM199910143411601","article-title":"Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group","volume":"341","author":"Matthay","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib19","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.ijrobp.2005.10.020","article-title":"Impact of TBI on late effects in children treated by megatherapy for Stage IV neuroblastoma. A study of the French Society of Pediatric Oncology","volume":"64","author":"Flandin","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib20","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/pbc.21713","article-title":"Outcomes of the POG 9340\/9341\/9342 trials for children with high-risk neuroblastoma: A report from the Children's Oncology Group","volume":"51","author":"Zage","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib21","unstructured":"Children's Oncology Group. ANBL0532. Comparing two different myeloablation therapies in treating young patients who are undergoing a stem cell transplant for high-risk neuroblastoma [NLM identifier NCT00567567]. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00567567. Accessed June 9,\u00a02015."},{"key":"10.1016\/j.ijrobp.2016.10.047_bib22","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.ijrobp.2014.07.019","article-title":"Radiation therapy to the primary and postinduction chemotherapy MIBG-avid sites in high-risk neuroblastoma","volume":"90","author":"Mazloom","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib23","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ijrobp.2014.04.004","article-title":"Likelihood of bone recurrence in prior sites of metastasis in patients with high-risk neuroblastoma","volume":"89","author":"Polishchuk","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib24","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/0360-3016(95)00011-M","article-title":"Patterns of failure following total body irradiation and bone marrow transplantation with or without a radiotherapy boost for advanced neuroblastoma","volume":"32","author":"Sibley","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib25","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1200\/JCO.1998.16.3.953","article-title":"Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: A report from the European Bone Marrow Transplantation Solid Tumor Registry","volume":"16","author":"Ladenstein","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib26","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.34.18_suppl.LBA3","article-title":"A phase III randomized clinical trial (RCT) of tandem myeloablative autologous stem cell transplant (ASCT) using peripheral blood stem cell (PBSC) as consolidation therapy for high-risk neuroblastoma (HR-NB): A Children's Oncology Group (COG) study","author":"Park","year":"2016","journal-title":"American Society of Clinical Oncology"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib27","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1200\/JCO.2010.34.3392","article-title":"Clinical and biologic features predictive of survival after relapse of neuroblastoma: A report from the International Neuroblastoma Risk Group project","volume":"29","author":"London","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib28","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1200\/JCO.2014.56.1621","article-title":"Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: A report from the International Neuroblastoma Risk Group project","volume":"32","author":"Vo","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib29","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1200\/JCO.1993.11.11.2226","article-title":"Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: A Childrens Cancer Group pilot study","volume":"11","author":"Matthay","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib30","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/bjc.2015.12","article-title":"Phase I\/II study of (131)I-MIBG with vincristine and 5 days of irinotecan for advanced neuroblastoma","volume":"112","author":"DuBois","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib31","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1200\/JCO.2005.03.6400","article-title":"Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: A new approaches to Neuroblastoma Therapy Consortium Study","volume":"24","author":"Matthay","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib32","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1200\/JCO.2006.09.3484","article-title":"Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma","volume":"25","author":"Matthay","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib33","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1002\/cncr.25987","article-title":"Response, survival, and toxicity after iodine-131-metaiodobenzylguanidine therapy for neuroblastoma in preadolescents, adolescents, and adults","volume":"117","author":"Polishchuk","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib34","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbmt.2014.12.008","article-title":"131I-metaiodobenzylguanidine with intensive chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma. A new approaches to neuroblastoma therapy (NANT) phase II study","volume":"21","author":"Yanik","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib35","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ejca.2008.01.010","article-title":"Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age","volume":"44","author":"de Kraker","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib36","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/sj.bjc.6694223","article-title":"131I-metaiodobenzylguanidine (131I-MIBG) therapy for residual neuroblastoma: A mono-institutional experience with 43 patients","volume":"81","author":"Garaventa","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2016.10.047_bib37","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/S0959-8049(98)00130-0","article-title":"Treatment of neuroblastoma stage 4 with 131I-meta-iodo-benzylguanidine, high-dose chemotherapy and immunotherapy. A pilot study","volume":"34","author":"Klingebiel","year":"1998","journal-title":"Eur J Cancer"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161633423X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161633423X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T22:57:34Z","timestamp":1536274654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030161633423X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S036030161633423X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2016.10.047","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of Relapse in High-Risk Neuroblastoma Patients Treated With and Without Total Body Irradiation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2016.10.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}